Researchers explore the potential of tau-targeting therapies in treating Alzheimer’s disease, focusing on immunotherapies and strategies to improve their efficacy. The study dives into the complex biology of tau proteins, their modifications, and how they can be targeted to halt the progression of Alzheimer’s.